1. Home
  2. AIMD vs GIGM Comparison

AIMD vs GIGM Comparison

Compare AIMD & GIGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIMD
  • GIGM
  • Stock Information
  • Founded
  • AIMD 1984
  • GIGM 1998
  • Country
  • AIMD United States
  • GIGM Taiwan
  • Employees
  • AIMD N/A
  • GIGM N/A
  • Industry
  • AIMD Biotechnology: Pharmaceutical Preparations
  • GIGM Computer Software: Programming Data Processing
  • Sector
  • AIMD Health Care
  • GIGM Technology
  • Exchange
  • AIMD Nasdaq
  • GIGM Nasdaq
  • Market Cap
  • AIMD 16.9M
  • GIGM 17.0M
  • IPO Year
  • AIMD N/A
  • GIGM 2000
  • Fundamental
  • Price
  • AIMD $3.43
  • GIGM $1.81
  • Analyst Decision
  • AIMD
  • GIGM
  • Analyst Count
  • AIMD 0
  • GIGM 0
  • Target Price
  • AIMD N/A
  • GIGM N/A
  • AVG Volume (30 Days)
  • AIMD 88.9K
  • GIGM 22.4K
  • Earning Date
  • AIMD 11-05-2025
  • GIGM 10-29-2025
  • Dividend Yield
  • AIMD N/A
  • GIGM N/A
  • EPS Growth
  • AIMD N/A
  • GIGM N/A
  • EPS
  • AIMD N/A
  • GIGM N/A
  • Revenue
  • AIMD $110,870.00
  • GIGM $3,250,000.00
  • Revenue This Year
  • AIMD N/A
  • GIGM N/A
  • Revenue Next Year
  • AIMD N/A
  • GIGM N/A
  • P/E Ratio
  • AIMD N/A
  • GIGM N/A
  • Revenue Growth
  • AIMD 70.25
  • GIGM N/A
  • 52 Week Low
  • AIMD $2.00
  • GIGM $1.30
  • 52 Week High
  • AIMD $5.00
  • GIGM $1.89
  • Technical
  • Relative Strength Index (RSI)
  • AIMD 49.24
  • GIGM 66.43
  • Support Level
  • AIMD $3.30
  • GIGM $1.61
  • Resistance Level
  • AIMD $3.61
  • GIGM $1.89
  • Average True Range (ATR)
  • AIMD 0.26
  • GIGM 0.09
  • MACD
  • AIMD -0.06
  • GIGM 0.02
  • Stochastic Oscillator
  • AIMD 18.29
  • GIGM 80.05

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

About GIGM GigaMedia Limited

GigaMedia Ltd is a diversified provider of digital entertainment services. Its only segment and principal business is digital entertainment service business, which operates a portfolio of digital entertainment products, targeting digital entertainment service users across Asia. It operates digital entertainment business in Taiwan, Hong Kong and Macau through FunTown.

Share on Social Networks: